Loading...
Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform
T-cell–directed killing of tumor cells using bispecific antibodies is a promising approach for the treatment of hematologic malignancies. Here we describe our preclinical work with a dual-affinity retargeting (DART) molecule generated from antibodies to CD3 and CD123, designed to redirect T cells ag...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4705603/ https://ncbi.nlm.nih.gov/pubmed/26531164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-05-575704 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|